Weekly Digest: New diabetes clinical trial (10 items)

New diabetes clinical trial: Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) Published on: March 14, 2022 at 06:00PM Conditions:   Type2 Diabetes;   Type 2 Diabetes Mellitus in Obese;   Dysglycemia;   Microvascular Complications;   Brain Structure;   Obesity, Childhood;   Diabetes in Adolescence;   Inflammation;   Insulin Resistance;   Overweight, Childhood;   Cognitive Decline Intervention:   Other: Observational Sponsors:   Washington University School of Medicine;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05277558?term=diabetes&sfpd_d=14 March 14, 2022 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Effect of Circadian Rhythm and Physical Exercise in Overweight Type 1 Diabetes Patients Published on: March 14, 2022 at 06:00PM Conditions:   Type 1 Diabetes;   Overweight Intervention:   Behavioral: High intensity interval training (HIIT) Sponsor:   Karolinska Institutet Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05277532?term=diabetes&sfpd_d=14 March 14, 2022 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Virtual SMAs in Lifestyle Approach for Type 2 Diabetes Published on: March 15, 2022 at 06:00PM Condition:   Diabetes Type 2 Intervention:   Behavioral: Virtual SMAs Sponsors:   Universidade do Porto;   Unidade de Saúde Familiar Homem do Leme;   Health4All Primary Healthcare Research Network Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05279326?term=diabetes&sfpd_d=14 March 15, 2022 at 09:22PM via ClinicalTrials.gov New diabetes clinical trial: A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes Published on: March 15, 2022 at 06:00PM Conditions:   Diabetes, Gestational;   PreDiabetes;   Diabetes Mellitus, Type 2 Intervention:   Drug: Metformin Sponsor:   Tufts Medical Center Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05280496?term=diabetes&sfpd_d=14 March 15, 2022 at 09:22PM via ClinicalTrials.gov New diabetes clinical trial: Acceptability of Hybrid Closed-loop Systems in Patients Living With Highly Unbalanced Type 1 Diabetes Published on: March 16, 2022 at 06:00PM Condition:   Type 1 Diabetes Intervention:   Other: device Sponsor:   Centre Hospitalier Sud Francilien Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05282264?term=diabetes&sfpd_d=14 March 16, 2022 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: The Hong Kong Diabetes Biobank Published on: March 16, 2022 at 06:00PM Conditions:   Diabetes Mellitus;   Type 2 Diabetes;   Type 1 Diabetes;   Diabetic Nephropathies;   Diabetic Kidney Disease;   Diabetic Angiopathies;   Cardiovascular Diseases;   Coronary Heart Disease;   Diabetic Retinopathy;   Stroke;   Diabetes Intervention:   Sponsor:   Chinese University of Hong Kong Recruiting https://clinicaltrials.gov/ct2/show/NCT05282680?term=diabetes&sfpd_d=14 March 16, 2022 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: The Impact of Glucotoxicity on Gastric Emptying in Chinese Patients With Newly Diagnosed Type 2 Diabetes Published on: March 17, 2022 at 06:00PM Condition:   Type 2 Diabetes Intervention:   Drug: Anti-Diabetics Sponsors:   University of Adelaide;   The First Affiliated Hospital with Nanjing Medical University Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT05284344?term=diabetes&sfpd_d=14 March 17, 2022 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation Published on: March 17, 2022 at 06:00PM Conditions:   Diabetes type1;   Diabetes type2 Intervention:   Device: Device: Actiste 1.0 and the Companion app with TBL Backend Sponsors:   Northern Care Alliance NHS Foundation Trust;   Brighter AB Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05284071?term=diabetes&sfpd_d=14 March 17, 2022 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: A Study of Renal Autologous Cell Therapy (REACT®) in Participants With Type 2 Diabetes and Chronic Kidney Disease Published on: March 18, 2022 at 06:00PM Conditions:   T2DM (Type 2 Diabetes Mellitus);   CKD (Chronic Kidney Disease) Intervention:   Biological: Renal Autologous Cell Therapy (REACT®) Sponsors:   Prokidney;   Iqvia Pty Ltd Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05286853?term=diabetes&sfpd_d=14 March 18, 2022 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Diabetes Learning in Virtual Environments Just in Time for Community Reentry Published on: March 18, 2022 at 06:00PM Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2 Interventions:   Other: Diabetes LIVE JustICE;   Other: Enhanced Education Sponsors:   Louise Reagan;   American Diabetes Association Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05286892?term=diabetes&sfpd_d=14 March 18, 2022 at 02:22PM via ClinicalTrials.gov